NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Thursday that its fourth quarter revenues sank 24 percent as increases in laboratory services and collaboration revenues were offset by a decrease in product sales.

For the three months ended Dec. 31, the company reported total revenues of $1.0 million, down from $1.3 million in Q4 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.